1. Reitz C, Mayeux R (2014) Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers. Biochem Pharmacol. doi: 10.1016/j.bcp.2013.12.024
2. Wang J, Yu JT, Wang HF, Meng XF, Wang C, Tan CC, Tan L (2014) Pharmacological treatment of neuropsychiatric symptoms in Alzheimer's disease: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. doi: 10.1136/jnnp-2014-308112
3. Jiang T, Yu JT, Tian Y, Tan L (2013) Epidemiology and etiology of Alzheimer's disease: from genetic to non-genetic factors. Curr Alzheimer Res 10(8):852–867
4. Yu JT, Tan L, Hardy J (2014) Apolipoprotein E in Alzheimer’s disease: an update. Annu Rev Neurosci. doi: 10.1146/annurev-neuro-071013-014300
5. Wang J, Yu JT, Jiang T, Tan MS, Wang HF, Tan L, Hu N, Sun L, Zhang W, Tan L (2014) Association of LRRTM3 polymorphisms with late-onset Alzheimer's disease in Han Chinese. Exp Gerontol 52:18–22. doi: 10.1016/j.exger.2014.01.013